GameStop, AstraZeneca and Twitter Rise Premarket By Investing.com

© Reuters

By Peter Nurse 

Investing.com — Stocks in focus in premarket trade on Thursday, April 8th. Please refresh for updates.

  • GameStop (NYSE:) stock rose 4.8% after the games company announced plans to elect Ryan Cohen, the videogame retailer’s biggest shareholder and board member, as chairman following its annual meeting.

  • ConAgra Foods (NYSE:) stock rose 0.7% after the packaged foods company updated its guidance, seeing sustained at-home product demand.

  • Constellation Brands (NYSE:) stock fell 3.4% after the brewer announced a fall in fourth-quarter profit, while also declaring a 1.5% increase in its quarterly dividend.

  • AstraZeneca (NASDAQ:) ADR rose 3.1% after the U.K. and European medical regulators acknowledged a possible link between the drug maker’s vaccine and potentially dangerous blot clotting disorders, but both argued that the benefits of taking it still outweigh the risks. 

  • Gilead (NASDAQ:) stock rose 0.8% after the biopharmaceutical company won full FDA approval for its breast cancer drug Trodelvy.

  • Twitter (NYSE:) stock rose 1.1% after Bloomberg reported that the social media giant held recent discussions to buy audio app Clubhouse for around $4 billion, but discussions were no longer ongoing.

  • Box (NYSE:) stock fell 8.1% after the cloud computing company announced a $500 million investment from funds run by private-equity firm KKR, with the company planning to use most of the funds for a stock buyback.

  • Costco (NASDAQ:) stock rose 0.9% after the membership-based retailer reported a 16% rise in same-store sales for March, including online sales surging over 57% compared with a year earlier.

  • Bilibili (NASDAQ:) stock rose 3.2% after Reuters reported that the Chinese online video site was in talks to buy a 24% stake in video game company Yoozoo Games as part of a nearly 5 billion yuan ($765 million) deal.

  • Canopy Growth (NASDAQ:) stock rose 1.5% after announcing it was buying Toronto-based Supreme Cannabis for 435 million Canadian dollars  ($345 million) in a stock and cash deal.

 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button